NBT Bank N A NY Lowers Position in iShares Biotechnology ETF (NASDAQ:IBB)

NBT Bank N A NY trimmed its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 1.0% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 28,980 shares of the financial services provider’s stock after selling 280 shares during the period. NBT Bank N A NY’s holdings in iShares Biotechnology ETF were worth $3,831,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Huntington National Bank raised its position in shares of iShares Biotechnology ETF by 17.9% during the 3rd quarter. Huntington National Bank now owns 1,054 shares of the financial services provider’s stock valued at $153,000 after buying an additional 160 shares in the last quarter. National Bank of Canada FI raised its position in iShares Biotechnology ETF by 5.9% during the third quarter. National Bank of Canada FI now owns 4,124 shares of the financial services provider’s stock valued at $600,000 after purchasing an additional 229 shares in the last quarter. IFP Advisors Inc lifted its stake in iShares Biotechnology ETF by 237.1% during the fourth quarter. IFP Advisors Inc now owns 16,018 shares of the financial services provider’s stock worth $2,118,000 after purchasing an additional 11,266 shares during the last quarter. Avior Wealth Management LLC boosted its holdings in shares of iShares Biotechnology ETF by 438.2% in the 3rd quarter. Avior Wealth Management LLC now owns 3,229 shares of the financial services provider’s stock worth $470,000 after purchasing an additional 2,629 shares in the last quarter. Finally, Healthcare of Ontario Pension Plan Trust Fund boosted its holdings in shares of iShares Biotechnology ETF by 32.9% in the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 663,000 shares of the financial services provider’s stock worth $96,533,000 after purchasing an additional 164,000 shares in the last quarter. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Trading Up 0.5 %

Shares of NASDAQ IBB opened at $136.95 on Monday. The stock’s 50-day moving average is $136.08 and its 200 day moving average is $140.22. The stock has a market cap of $6.47 billion, a price-to-earnings ratio of 24.52 and a beta of 0.84. iShares Biotechnology ETF has a 1-year low of $123.60 and a 1-year high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The firm also recently declared a dividend, which was paid on Friday, December 20th. Shareholders of record on Tuesday, December 17th were paid a dividend of $0.0624 per share. The ex-dividend date of this dividend was Tuesday, December 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.